FdaApplication
ANDA 211015
Identifiers
- fda_app_no: ANDA211015
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2018-06-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | 5MG/2ML (2.5MG/ML) | SOLUTION;INTRAVENOUS |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | 10MG/4ML (2.5MG/ML) | SOLUTION;INTRAVENOUS |
2 products